Rank;Global Rank;Institution;Country;Sector
1;95;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies;
2;100;Genentech Inc;USA;Companies;
3;103;Sanofi, United States;USA;Companies;
4;111;Hoffmann-La Roche Ltd, United States;USA;Companies;
5;160;Bristol-Myers Squibb Company, United States;USA;Companies;
6;181;AstraZeneca, United States;USA;Companies;
7;210;GlaxoSmithKline, United States;USA;Companies;
8;248;Merck & Co Inc, United States;USA;Companies;
9;250;Boehringer Ingelheim GmbH Germany;DEU;Companies;
10;290;Eli Lilly and Company, United States;USA;Companies;
11;297;GlaxoSmithKline, United Kingdom;GBR;Companies;
12;310;Regeneron Pharmaceuticals Inc *;USA;Companies;
13;340;AstraZeneca, Sweden;SWE;Companies;
14;459;AstraZeneca, United Kingdom;GBR;Companies;
15;489;Bayer AG, Germany;DEU;Companies;
16;537;Sanofi, France;FRA;Companies;
17;572;Analysis Group Inc;USA;Companies;
18;662;Novartis, Switzerland;CHE;Companies;
19;762;Boehringer Ingelheim, USA;USA;Companies;
20;833;Bosch, Germany;DEU;Companies;
21;1352;Takeda Pharmaceuticals International Inc, USA;USA;Companies;
22;1365;Pharmaceutical Product Development LLC;USA;Companies;